rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Alison S. Long

Director

Company insider

Files Form 4 as: Director, Taysha Gene Therapies; Chief Medical Officer, Kaleido Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
15 Dec 2021
Last trade
1 Jun 2026
Last filed
2 Jun 2026

Companies traded

Where they are an officer
Kaleido BiosciencesOfficer · last 14 Jan 20220 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TSHA Taysha Gene TherapiesDirector · Biotechnology · last 1 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
1 Jun 2026filed 2 Jun 2026TSHA Taysha Gene TherapiesBiotechnologySEC FORM 4 Code A—21,335 at $0.00filing
1 Jun 2026filed 2 Jun 2026TSHA Taysha Gene Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—42,671 at $0.00filing
1 Jun 2026filed 2 Jun 2026TSHA Taysha Gene Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—42,671 at $0.00filing
1 Jun 2026filed 2 Jun 2026TSHA Taysha Gene TherapiesBiotechnologySEC FORM 4 Code A—21,335 at $0.00filing
2 Jun 2025filed 4 Jun 2025TSHA Taysha Gene Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—113,246 at $0.00filing
2 Jun 2025filed 4 Jun 2025TSHA Taysha Gene TherapiesBiotechnologySEC FORM 4 Code A—56,623 at $0.00filing
29 May 2024filed 31 May 2024TSHA Taysha Gene Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—98,440 at $0.00filing
29 May 2024filed 31 May 2024TSHA Taysha Gene TherapiesBiotechnologySEC FORM 4 Code A—49,220 at $0.00filing
1 Nov 2023filed 3 Nov 2023TSHA Taysha Gene Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—43,800 at $0.00filing
14 Jan 2022filed 18 Jan 2022Kaleido Biosciencesoption or derivativeSEC FORM 4 Code A—46,800 at $0.00filing
14 Jan 2022filed 18 Jan 2022Kaleido Biosciencesoption or derivativeSEC FORM 4 Code A—125,000 at $0.00filing
15 Dec 2021filed 16 Dec 2021Kaleido Biosciencesoption or derivativeSEC FORM 4 Code A—300,000 at $0.00filing
15 Dec 2021filed 16 Dec 2021Kaleido Biosciencesoption or derivativeSEC FORM 4 Code A—24,350 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.